ArticleCancer immunology, immunotherapy : CII2013

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses.

Hyun-Il Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.